Pittsburgh Business Times’s Fastest Growing Company for Third Consecutive Year

August 22nd PANTHERx® Specialty Pharmacy was recognized by the Pittsburgh Business Times as the #1 Fastest Growing Company in Pittsburgh for 2018. This is the third consecutive year that PANTHERx® Specialty Pharmacy captured the top spot on Pittsburgh Business Times’ list of Fastest Growing Companies.

“Three years in a row to be recognized as #1 by Pittsburgh Business Times reaffirms our sustained commitment to continued innovation so that we may provide exceptional service and quality of care to our patients, providers, and partners,” said Dr. Gordon J. Vanscoy, Chairman and CEO. “Although the growth isn’t slowing for PANTHERx® , we hope that our newest venture, RareMed Solutions, a rare disease patient services company, will someday vie for this honor.”

About the Pittsburgh Business Times Fast 50 Awards
The Pittsburgh Business Times hosts the 2018 Fast 50 Awards to celebrate the success of companies in the Pittsburgh region with rapid revenue growth between 2015 and 2017. PANTHERx® Leadership attended the award ceremony, held at the Rivers Casino on August 22nd, to receive the award on behalf of PANTHERx®.

Read the PANTHERx Fast 50 announcement from the Pittsburgh Business Times: https://www.bizjournals.com/pittsburgh/news/2018/08/22/fast-50-1-pantherx-specialty-pharmacys-team.html


PANTHERx® Climbs to Inc. Magazine’s 49th Fastest-Growing Company

PANTHERx® Specialty Pharmacy, The Rare Disease Specialty Pharmacy®, is thrilled and proud to announce that it has been named to the 37th Annual Inc. 5000 list, recognizing the fastest-growing private companies in America. PANTHERx® is being recognized on this prestigious national list for the third year in a row and this year as the 49th fastest growing company overall and the 5th fastest growing company in Health. Regionally, PANTHERx® is the #1 fastest growing company in Pennsylvania and #1 in Pittsburgh.

About the Inc. Results: Moving Up 16 Slots
The 2018 Inc. 5000 achieved an astounding three-year average growth rate of 538.2 percent, and a median growth rate of 171.8 percent. The Inc. 5000’s aggregate revenue was $206.1 billion in 2017, accounting for 664,095 jobs over the past three years. PANTHERx® Specialty’s rank at #49 reflects its 5,436 percent three-year growth rate, and the ability of Dr. Gordon Vanscoy, CEO and Chairman, and his team to grow PANTHERx®’s revenue to nearly a half billion dollars last year. Analysis reveals that PANTHERx® had the #1 highest revenue of the top 500 companies on the 2018 list.

“PANTHERx® Specialty is proud to be ranked near the top of the Inc. 5000 list for a third consecutive year. Growing from such high numbers over the past years is the real achievement, and this year is on track to be another record-setting year. Our #49 ranking for 2018, rising 16 slots from last year, emphasizes our passion and persistence in transforming the lives of patients with rare and devastating conditions,” said Dr. Gordon J. Vanscoy, Chairman and CEO. “We continue to innovatively and attentively address the needs of our partners, prescribers, and, most importantly, our patients, by emulating the original approach to specialty pharmacy that has at its core the profound desire to improve the lives of medically vulnerable people in need of superior services. A primary contributor to the growth is our unwavering dedication to caring for our patients and we take pride in being ranked #1 in patient satisfaction* for the second year in a row.”

PANTHERx® Specialty will be recognized among other Inc. 5000 honorees at the 37th Annual Inc. 5000 Conference and Awards Ceremony, taking place October 17-19, 2018 in San Antonio, Texas.

For further information, please contact: media@pantherspecialty.com.
To view PANTHERx®’s Inc. 5000 profile, please visit: https://www.inc.com/profile/pantherx-specialty-pharmacy.